We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
39 hedge funds and large institutions have $84M invested in Regulus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $95K | +$78K | +82 | New |
|
|
AIG
27
American International Group
New York
| $87.5K | +$70.3K | +74 | New |
|
28
AllianceBernstein
Nashville,
Tennessee
| $86K | +$69.4K | +73 | New |
|
|
NFA
29
Nationwide Fund Advisors
Columbus,
Ohio
| $83K | +$66.5K | +70 | New |
|
|
U
30
UBS
Zurich,
Switzerland
| $74K | +$58.9K | +62 | New |
|
31
Barclays
London,
United Kingdom
| $65K | +$52.3K | +55 | New |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $59K | +$47.5K | +50 | New |
|
33
Bank of America
Charlotte,
North Carolina
| $48K | +$39K | +41 | New |
|
|
BA
34
BlackRock Advisors
Wilmington,
Delaware
| $44K | +$35.2K | +37 | New |
|
|
RFC
35
Russell Frank Company
Seattle,
Washington
| $43K | +$37.1K | +39 | New |
|
|
BJ
36
BlackRock Japan
Tokyo,
Japan
| $27K | +$21.9K | +23 | New |
|
37
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $9K | +$7.61K | +8 | New |
|
38
California Public Employees Retirement System
Sacramento,
California
| $5K | +$3.8K | +4 | New |
|
39
Ameriprise
Minneapolis,
Minnesota
| $5K | +$4.75K | +5 | New |
|
RGLS Hedge Fund Activity: Q2 2013 in Review
39 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regulus Therapeutics (RGLS) for Q2 2013, worth a combined $84M.
Buyers outnumbered sellers: 39 funds opened new RGLS positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
- 39 institutional investors held Regulus Therapeutics (RGLS) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $84M of Regulus Therapeutics stock for Q2 2013.
- 39 funds opened new Regulus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +39 holders.
Based on aggregated 13F filings for Q2 2013.